Nathan Rehmer
Overview
Explore the profile of Nathan Rehmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bostick B, Habibi J, Ma L, Aroor A, Rehmer N, Hayden M, et al.
Metabolism
. 2014 Jun;
63(8):1000-11.
PMID: 24933400
Objective: Consumption of a high-fat/high-fructose Western diet (WD) is linked to rising obesity and heart disease, particularly diastolic dysfunction which characterizes early obesity/metabolic cardiomyopathy. Mounting evidence supports a role for...
2.
Whaley-Connell A, Habibi J, Rehmer N, Ardhanari S, Hayden M, Pulakat L, et al.
Metabolism
. 2013 Jan;
62(6):861-72.
PMID: 23352204
Objective: Strategies that block angiotensin II actions on its angiotensin type 1 receptor or inhibit actions of aldosterone have been shown to reduce myocardial hypertrophy and interstitial fibrosis in states...
3.
Whaley-Connell A, Nistala R, Habibi J, Hayden M, Schneider R, Johnson M, et al.
Am J Physiol Renal Physiol
. 2009 Dec;
298(3):F655-61.
PMID: 20007350
Renin-angiotensin system (RAS) activation contributes to kidney injury through oxidative stress. Renin is the rate-limiting step in angiotensin (ANG II) generation. Recent work suggests renin inhibition improves proteinuria comparable to...
4.
Whaley-Connell A, Habibi J, Johnson M, Tilmon R, Rehmer N, Rehmer J, et al.
Am J Nephrol
. 2009 Jul;
30(4):354-60.
PMID: 19609077
Background/aims: Renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system activation are crucial in the pathogenesis of hypertension, cardiovascular and renal disease. NADPH oxidase-mediated increases in reactive oxygen species (ROS) are an...
5.
Wei Y, Whaley-Connell A, Habibi J, Rehmer J, Rehmer N, Patel K, et al.
Hypertension
. 2008 Dec;
53(2):158-65.
PMID: 19114643
Emerging evidence indicates that mineralocorticoid receptor (MR) blockade reduces the risk of cardiovascular events beyond those predicted by its blood pressure-lowering actions; however, the underlying mechanisms remain unclear. To investigate...
6.
Whaley-Connell A, Habibi J, Nistala R, Cooper S, Karuparthi P, Hayden M, et al.
Hypertension
. 2008 Jan;
51(2):474-80.
PMID: 18172055
Activation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase by angiotensin II is integral to the formation of oxidative stress in the vasculature and the kidney. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibition is...
7.
Whaley-Connell A, Morris E, Rehmer N, Yaghoubian J, Wei Y, Hayden M, et al.
Am J Nephrol
. 2007 Jan;
27(1):15-23.
PMID: 17204833
Background: Rac1 is a Rho-family small GTP-ase, when activated is pivotal in NAD(P)H oxidase (NOX) activation and generation of reactive oxygen species (ROS). Evidence links Rac1 activation to receptor-mediated albumin...